Showing 1681-1690 of 2529 results for "".
- Chinese Biotechnology Company Unveils Landmark Regenerative Aesthetic Medicine Innovationhttps://modernaesthetics.com/news/chinese-biotechnology-company-unveils-landmark-regenerative-aesthetic-medicine-innovation/2475368/Shanghai Moyom Biotechnology Co., Ltd. Announced the introduction of its new regenerative aesthetic product, Aphranel MagiCCrystal CaHA Filler, at an international event held at the Grand Halls on Shanghai’s Bund Themed “APHRANEL: Code Breaker, World Maker.” Aphranel MagiCCrystal CaHA Fil
- Dr. David Shafer Explains Benefits of Breast Augmentation Visualization Toolhttps://modernaesthetics.com/news/dr-david-shafer-explains-benefits-of-breast-augmentation-visualization-tool/2475364/The Natrelle Breast Visualizer, powered by Crisalix, allows patients to preview their potential breast augmentation results in just a few clicks. Modern Aesthetics spoke with double board-certified plastic surgeon David Shafer, MD, FACS, about the challenges this technology help
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://modernaesthetics.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Teoxane Launches Consumer Access to Dermocosmetic Skincare Line in U.S.https://modernaesthetics.com/news/teoxane-launches-consumer-access-to-dermocosmetic-skincare-line-in-us/2475362/Teoxane has announced the U.S. launch of its dermocosmetics line, making its clinically developed skincare products available directly to consumers for the first time through its new online platform, teoxane.us. Previously offered exclusively through aesthetic professionals, the Swiss comp
- Allergan Aesthetics Appoints Inaugural AMI Training Center Facultyhttps://modernaesthetics.com/news/allergan-aesthetics-appoints-inaugural-ami-training-center-faculty/2475356/Allergan Aesthetics, an AbbVie company, has introduced the first faculty cohort for its new Allergan Medical Institute® (AMI) Training Centers in Orange County, CA, and Atlanta, GA. The new AMI Training Center Faculty will lead immersive educational programs designed to train and support the next
- Bausch Health Launches Fraxel FTX™ at ASLMS 2025https://modernaesthetics.com/news/bausch-health-launches-fraxel-ftx-at-aslms-2025/2475353/Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a natio
- Candela Launches Dual-Wavelength Vbeam Pro for Vascular and Dermatologic Conditionshttps://modernaesthetics.com/news/candela-launches-dual-wavelength-vbeam-pro-for-vascular-and-dermatologic-conditions/2475352/Candela has introduced its latest pulsed dye laser platform, the Vbeam Pro, at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) in Orlando, Florida. The new system is FDA-cleared
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- Evolus Launches “Drop the F Word” Campaign Ahead of Evolysse Injectable HA Gelshttps://modernaesthetics.com/news/evolus-launches-drop-the-f-word-campaign-ahead-of-evolysse-injectable-ha-gels/2475348/Evolus, Inc. rolled out a new campaign, “Drop the F Word,” ahead of the upcoming commercial launch of EvolysseTM injectable hyaluronic acid gels. The campaign aims to challenge outdated perceptions and language in the aesthetics industry, according to a press release, and introduces Ev
- Research Firm Executive Explains Optimistic Market Forecasthttps://modernaesthetics.com/news/research-firm-executive-explains-optimistic-market-forecast/2475344/The research firm Clarivate projected the global aesthetics market to reach a value of €22.9 billion by 2028, growing at a compound annual growth rate (CAGR) of nearly 8%. This growth, Clarivate said, is driven by trends such as the shift toward natural-looking treatments, the rise of combination